Sinsin Pharmaceutical Co. Ltd (002800) — Capital Reinvestment Ratio
Sinsin Pharmaceutical Co. Ltd (002800) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.70 Billion) in capital expenditures (₩871.54 Million). See Sinsin Pharmaceutical Co. Ltd (002800) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinsin Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks Sinsin Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Check how aggressively does Sinsin Pharmaceutical Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for Sinsin Pharmaceutical Co. Ltd from 2015 to 2024. For live market cap and broader valuation context, see market value of Sinsin Pharmaceutical Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩5.94 Billion | ₩1.51 Billion | ▼ -80.1% |
| 2023 | 1.28x | ₩3.93 Billion | ₩5.03 Billion | ▲ +670.0% |
| 2022 | 0.17x | ₩5.46 Billion | ₩907.13 Million | ▼ -99.9% |
| 2021 | 115.70x | ₩23.18 Million | ₩2.68 Billion | ▲ +1702.9% |
| 2020 | 6.42x | ₩1.87 Billion | ₩11.97 Billion | ▼ -80.5% |
| 2018 | 32.86x | ₩774.24 Million | ₩25.44 Billion | ▲ +4103.1% |
| 2017 | 0.78x | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.6% |
| 2016 | 2.66x | ₩2.79 Billion | ₩7.43 Billion | ▲ +166.7% |
| 2015 | 1.00x | ₩5.24 Billion | ₩5.22 Billion | — |